Santosa Sylvia, Farnworth Edward, Jones Peter J H
School of Dietetics and Human Nutrition, McGill University, Ste Anne-de-Bellevue, Québec, Canada.
Nutr Rev. 2006 Jun;64(6):265-74. doi: 10.1111/j.1753-4887.2006.tb00209.x.
Many studies have attempted to identify specific positive health effects of probiotics. One of the challenges in generalizing health effects of probiotics is that different strains exert disparate effects on human health. As a result, the efficacy of one strain or species cannot necessarily be inferred from another. The objective of this review is to examine the current scientific literature that could be used as the basis for potential health claims. More specifically, this paper will review existing evidence of different probiotic strains to prevent and treat diarrhea, treat irritable bowel syndrome (IBS), treat inflammatory bowel disease, and prevent colon cancer. The strongest evidence is related to the use of Lactobacillus rhamnosus GG in the prevention and treatment of rotavirus-associated diarrhea. Further examination of the literature also shows promise in the treatment of some forms of IBS with probiotics. Future studies that use consistent supplementation regimes will allow more definitive conclusions to be drawn on the effects of probiotics on IBS, inflammatory bowel disease, and colon cancer.
许多研究试图确定益生菌对健康的具体积极影响。概括益生菌对健康的影响面临的挑战之一是,不同菌株对人类健康产生的影响各不相同。因此,不能必然地从一种菌株或物种的功效推断出另一种的功效。本综述的目的是审视当前可作为潜在健康声明依据的科学文献。更具体地说,本文将回顾不同益生菌菌株预防和治疗腹泻、治疗肠易激综合征(IBS)、治疗炎症性肠病以及预防结肠癌的现有证据。最有力的证据与鼠李糖乳杆菌GG用于预防和治疗轮状病毒相关性腹泻有关。对文献的进一步研究还表明,益生菌在治疗某些形式的肠易激综合征方面也有前景。未来采用一致补充方案的研究将能就益生菌对肠易激综合征、炎症性肠病和结肠癌的影响得出更明确的结论。